Compare CRUS & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRUS | CHE |
|---|---|---|
| Founded | 1984 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.1B |
| IPO Year | 1997 | 1994 |
| Metric | CRUS | CHE |
|---|---|---|
| Price | $117.88 | $531.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $157.00 | ★ $501.50 |
| AVG Volume (30 Days) | ★ 760.7K | 159.4K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | ★ 30.83 | N/A |
| EPS | 1.47 | ★ 9.97 |
| Revenue | $1,997,379,000.00 | ★ $2,529,978,000.00 |
| Revenue This Year | $7.12 | $6.56 |
| Revenue Next Year | $0.49 | $6.23 |
| P/E Ratio | $79.51 | ★ $53.08 |
| Revenue Growth | ★ 5.34 | 4.06 |
| 52 Week Low | $111.00 | $365.21 |
| 52 Week High | $180.42 | $557.00 |
| Indicator | CRUS | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 29.69 | 57.68 |
| Support Level | $116.90 | $417.56 |
| Resistance Level | $127.01 | $554.34 |
| Average True Range (ATR) | 4.81 | 12.69 |
| MACD | -0.10 | -4.09 |
| Stochastic Oscillator | 13.17 | 33.20 |
Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.